Search Results
- < Prev
1 of 1
- Next >
News Releases
-
May 10, 2013, 16:00 ET
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO™ ELLIPTA™ as an inhaled long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive...
More news about: GlaxoSmithKline , Theravance, Inc.
-
Apr 30, 2013, 09:30 ET
The Zacks Analyst Blog Highlights: Merck, GlaxoSmithKline, VIVUS, Santarus and Celgene
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Merck & Co. Inc. (NYSE:MRK), GlaxoSmithKline...
More news about: Zacks Investment Research, Inc. , Merck & Co. Inc. , GlaxoSmithKline , VIVUS Inc. , Santarus, Inc. , Celgene Corporation
-
Apr 23, 2013, 08:00 ET
Avalon Ventures Enters Strategic Collaboration with GlaxoSmithKline to Fund and Launch Up to Ten Life Science Companies
Avalon Ventures today announced that it has entered into a collaboration with GlaxoSmithKline (GSK) to fund and launch up to ten early-stage life science companies in San Diego. This first-of-its-kind collaboration combines Avalon Ventures' successful approach of investing in early-stage life...
More news about: Avalon Ventures , GlaxoSmithKline
-
Apr 17, 2013, 17:18 ET
FDA Advisory Committee recommends approval of BREO™ ELLIPTA™ for the treatment of COPD
GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Pulmonary-Allergy Drugs Advisory Committee (PADAC) to the US Food and Drug Administration (FDA) voted that the efficacy and safety data provide substantial evidence to support approval of...
More news about: GlaxoSmithKline plc , Theravance, Inc.
-
Apr 17, 2013, 11:54 ET
GlaxoSmithKline, Triangle Community Foundation Issue Call for Applications Totaling $400,000 in GSK IMPACT Awards
GlaxoSmithKline (GSK) and Triangle Community Foundation today issued the 2013 GSK IMPACT Awards Call for Applications. This annual awards program will honor up to ten local nonprofits in Research Triangle Park, NC and the surrounding region with $40,000 each in recognition of their achievements...
More news about: GlaxoSmithKline , Triangle Community Foundation , 2013 GSK IMPACT Awards
-
Apr 17, 2013, 11:05 ET
GlaxoSmithKline Issues Call for Applications Totaling $400,000 in GSK IMPACT Awards
GlaxoSmithKline (@GSKUS) today issued the 2013 GSK IMPACT Awards Call for Applications. This annual awards program will honor up to ten local nonprofits in the Greater Philadelphia Region with $40,000 each in recognition of their achievements and innovations in improving community health....
More news about: GlaxoSmithKline
-
Apr 16, 2013, 09:31 ET
Critical Trade Alerts For Netflix, Wynn Resorts, GlaxoSmithKline, Fossil, and ADT Released By InvestorsObserver
InvestorsObserver issues critical PriceWatch Alerts for NFLX, WYNN, GSK, FOSL, and ADT. (Photo: http://photos.prnewswire.com/prnh/20120712/CG39046) To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at...
More news about: InvestorsObserver , Netflix, Inc. , Wynn Resorts Ltd. , GlaxoSmithKline plc , Fossil, Inc. , The ADT Corporation
-
Apr 06, 2013, 18:42 ET
GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today
GlaxoSmithKline (@GSKUS) officially opened its new double LEED® platinum certified facility in Philadelphia's Navy Yard Corporate Center today, ushering in a new era of how people work in Philadelphia. Employees, families and friends will celebrate and attend a ribbon-cutting ceremony...
More news about: GlaxoSmithKline , Synterra Partners , Liberty Property Trust , Francis Cauffman , Robert A.M. Stern Architects , The Navy Yard , The Navy Yard Corporate Center
-
Apr 05, 2013, 10:25 ET
GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
GlaxoSmithKline (@GSKUS) officially opens its new double LEED® platinum certified facility in Philadelphia's Navy Yard Corporate Center this Saturday, ushering in a new era of how people work in Philadelphia. Employees, families and friends will celebrate and attend a ribbon-cutting...
More news about: GlaxoSmithKline , Liberty Property Trust , Synterra Partners
-
Apr 01, 2013, 14:24 ET
Statement from GlaxoSmithKline Consumer Healthcare on FDA Report Regarding FDA's Changes to the Labeling of Over-the-Counter Nicotine Medications
The U.S. Food and Drug Administration (FDA) today announced a recommendation to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy (NRT) products. As leaders in smoking cessation, GlaxoSmithKline (GSK) Consumer Healthcare commends the...
More news about: GlaxoSmithKline Consumer Healthcare , GlaxoSmithKline Consumer Healthcare
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |